文献速递细菌感染、耐药与抗菌药物医院感染防控

基于侧链交叉反应图表与强化过敏评估改善β-内酰胺过敏患者手术预防用药

Impact of an Antibiotic Side-Chain-Based Cross-reactivity Chart Combined With Enhanced Allergy Assessment Processes for Surgical Prophylaxis Antimicrobials in Patients With β-Lactam Allergies.
PubMed 文献 · Clin Infect Dis · 2021-01-01

该单中心准实验研究分析了有β-内酰胺过敏记录的成人手术患者,比较实施基于侧链的交叉反应图表及强化过敏评估流程前后的抗生素处方。干预组接受β-内酰胺替代抗生素的比例显著降低(84.9% vs 15.1%,P < .001),30天再入院率下降(7.9% vs 6.3%,P = .035),但再入院患者手术部位感染率无差异(14.8% vs 13%,P = .765)。

要点

  • 基于侧链交叉反应图表联合强化过敏评估可显著增加β-内酰胺类手术预防用药。
  • 干预后30天再入院率降低,但再入院患者手术部位感染率无显著变化。
  • 过敏反应、死亡率、艰难梭菌感染等安全性结局无显著差异。

核心结论

  • 实施基于抗生素侧链的交叉反应图表联合强化过敏评估流程,显著改善了手术预防中β-内酰胺类抗生素的处方。

研究设计与样本

  • 单中心准实验研究,纳入2012年Q1至2014年Q3(历史组)和2016年Q3至2018年Q3(干预组)所有有β-内酰胺过敏记录且接受住院手术的成人患者。
  • 历史组1119例,干预组1089例,采用倾向性加权评分分析比较分类和连续结局,并进行中断时间序列分析。

主要发现

  • 干预组接受β-内酰胺替代抗生素的患者比例显著低于历史组(84.9% vs 15.1%;P < .001)。
  • 干预组30天再入院率显著降低(7.9% vs 6.3%;P = .035)。
  • 再入院患者中手术部位感染发生率两组无显著差异(14.8% vs 13%;P = .765)。
  • 过敏反应(0.5% vs 0.3%;P = .323)、手术部位感染、院内及30天死亡率、医疗设施起始艰难梭菌感染、急性肾损伤或住院费用均无显著差异。

关键数值与推荐

  • 基于β-内酰胺环R基侧链的交叉反应图表用于指导结构不同的β-内酰胺类药物选择。
  • 干预组β-内酰胺类抗生素使用比例从15.1%显著增加(历史组84.9%使用替代抗生素,P < .001)。

临床怎么用

  • 对于有β-内酰胺过敏记录的手术患者,可借助基于侧链的交叉反应图表和强化过敏评估流程,安全地增加β-内酰胺类药物的预防使用。

局限性

  • 单中心准实验设计,可能存在未控制的混杂因素。
  • 研究期间跨度较长,历史对照可能受时段差异影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: β-Lactam antibiotics are first-line therapy for perioperative prophylaxis; however, patient-reported allergies often lead to increased prescribing of alternative antibiotics that may increase the incidence of surgical site infections. The R-group side chain of the β-lactam ring is responsible for allergic cross-reactivity and experts recommend the use of β-lactams that are structurally dissimilar. METHODS: An internally developed, antibiotic side-chain-based cross-reactivity chart was developed and implemented alongside enhanced allergy assessment processes. This single-center, quasi-experimental study analyzed antibiotic prescribing in all adult patients with a documented β-lactam allergy undergoing an inpatient surgical procedure between quartile (Q) 1 (2012)-Q3 (2014) (historical group) and Q3 (2016)-Q3 (2018) (intervention group). Propensity-weighted scoring analyses compared categorical and continuous outcomes. Interrupted time-series analysis further analyzed key outcomes. RESULTS: A total of 1119 and 1089 patients were included in the historical and intervention cohorts, respectively. There was a significant difference in patients receiving a β-lactam alternative antibiotic between cohorts (84.9% vs 15.1%; P < .001). There was a decrease in 30-day readmissions in the intervention cohort (7.9% vs 6.3%; P = .035); however, there was no difference in the incidence of SSIs in patients readmitted (14.8% vs 13%; P = .765). No significant differences were observed in allergic reactions (0.5% vs 0.3%; P = .323), surgical site infections, in-hospital and 30-day mortality, healthcare facility-onset Clostridiodes difficile infection, acute kidney injury, or hospital costs. CONCLUSIONS: Implementation of an antibiotic cross-reactivity chart combined with enhanced allergy assessment processes significantly improved the prescribing of β-lactam antibiotics for surgical prophylaxis.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Collins CD, Scheidel C, Anam K, et al. Impact of an Antibiotic Side-Chain-Based Cross-reactivity Chart Combined With Enhanced Allergy Assessment Processes for Surgical Prophylaxis Antimicrobials in Patients With β-Lactam Allergies. Clin Infect Dis. 2021. PMID: 32155264. doi:10.1093/cid/ciaa232

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。